If you need more lookups,
subscriptions start at $34 USD/month.
Ruben Rizzi Location
Mainz, RP, DE
Ruben Rizzi Work
SVP Global Regulatory Affairs, Safety and Pharmacovigilance @ (November 2025 - Present)
Senior Vice President Global Regulatory Affairs @ (January 2024 - November 2025)
Vice President Global Regulatory Affairs @ (July 2021 - February 2024)
Director Global Regulatory Affairs @ (November 2020 - July 2021)
Regulatory Affairs Strategist @ (December 2019 - November 2020)
Regulatory Development Manager and Medical Advisor @ (January 2018 - December 2019)
Medical Advisor, Corporate Direction Regulatory Activities and Market Access @ (June 2013 - December 2017)
Locum Physician @ Lavoratore autonomo (February 2013 - June 2013)
Internship @ IRCCS San Martino - IST (December 2011 - February 2013)
Ruben Rizzi Education
Università degli Studi di Genova 2012-2013
Università degli Studi di Milano-Bicocca 2006-2012
Liceo Scientifico Statale Lorenzo Mascheroni, Bergamo 2001-2006
Ruben Rizzi Skills
Industria farmaceutica
Microsoft Office
Lifesciences
Sviluppo Clinico
Regulatory Guidelines
Medicine
Ricerca
Pharmaceutical Industry
Regulatory Affairs
Drug Development
Medicina
Healthcare
Pharmaceutics
Market Access
Oncologia
Farmaceutica
Aree Terapeutiche
Medical Affairs
Ricerca clinica
Regulatory Intelligence
Biologics
Small Molecules
Advisory Boards
Regulatory Strategy Development
Clinical Development
CTAs
IND
u.s. Food and Drug Administration
Cder
Cdrh
EMA
Pip
In Vitro Diagnostics
Ctc
Ruben Rizzi Summary
Ruben Rizzi, based in Mainz, RP, DE, is currently a SVP Global Regulatory Affairs, Safety and Pharmacovigilance at BioNTech SE. Ruben Rizzi brings experience from previous roles at BioNTech SE. Ruben Rizzi holds a 2012 - 2013 Università degli Studi di Genova. With a robust skill set that includes Industria farmaceutica, Microsoft Office, Lifesciences, Sviluppo Clinico, Regulatory Guidelines and more. Ruben Rizzi has 2 emails on RocketReach.
Looking for a different Ruben Rizzi?
Find contact details for 700 million professionals.